Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion

被引:194
作者
Sundrud, MS
Torres, VJ
Unutmaz, D [1 ]
Cover, TL
机构
[1] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[3] Vet Affairs Med Ctr, Nashville, TN 37212 USA
关键词
D O I
10.1073/pnas.0401528101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent evidence indicates that the secreted Helicobacter pylori vacuolating toxin (VacA) inhibits the activation of T cells. VacA blocks IL-2 secretion in transformed T cell lines by suppressing the activation of nuclear factor of activated T cells (NFAT). In this study, we investigated the effects of VacA on primary human CD4(+) T cells. VacA inhibited the proliferation of primary human T cells activated through the T cell receptor (TCR) and CD28. VacA-treated Jurkat T cells secreted markedly diminished levels of IL-2 compared with untreated cells, whereas VacA-treated primary human T cells continued to secrete high levels of IL-2. Further experiments indicated that the VacA-induced inhibition of primary human T cell proliferation was not attributable to VacA effects on NFAT activation or IL-2 secretion. We show here that VacA suppresses IL-2-induced cell-cycle progression and proliferation of primary human T cells without affecting IL-2-dependent survival. Through the analysis of a panel of mutant VacA proteins, we demonstrate that VacA-mediated inhibition of T cell proliferation requires an intact N-terminal hydrophobic region necessary for the formation of anion-selective membrane channels. Remarkably, we demonstrate that one of these mutant VacA proteins [VacA-Delta(6-27)] abrogates the immunosuppressive actions of wild-type VacA in a dominant-negative fashion. We suggest that VacA may inhibit the clonal expansion of T cells that have already been activated by H. pylori antigens, thereby allowing H. pylori to evade the adaptive immune response and establish chronic infection.
引用
收藏
页码:7727 / 7732
页数:6
相关论文
共 38 条
[1]   Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells [J].
Akhiani, AA ;
Pappo, J ;
Kabok, Z ;
Schön, K ;
Gao, W ;
Franzén, LE ;
Lycke, N .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6977-6984
[2]   MOSAICISM IN VACUOLATING CYTOTOXIN ALLELES OF HELICOBACTER-PYLORI - ASSOCIATION OF SPECIFIC VACA TYPES WITH CYTOTOXIN PRODUCTION AND PEPTIC-ULCERATION [J].
ATHERTON, JC ;
CAO, P ;
PEEK, RM ;
TUMMURU, MKR ;
BLASER, MJ ;
COVER, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :17771-17777
[3]   The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms [J].
Boncristiano, M ;
Paccani, SR ;
Barone, S ;
Ulivieri, C ;
Patrussi, L ;
Ilver, D ;
Amedei, A ;
D'Elios, MM ;
Telford, JL ;
Baldari, CT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1887-1897
[4]   RAPAMYCIN FKBP SPECIFICALLY BLOCKS GROWTH-DEPENDENT ACTIVATION OF AND SIGNALING BY THE 70 KD S6 PROTEIN-KINASES [J].
CHUNG, J ;
KUO, CJ ;
CRABTREE, GR ;
BLENIS, J .
CELL, 1992, 69 (07) :1227-1236
[5]  
Cover TL, 2003, CANCER RES, V63, P951
[6]   Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly [J].
Cover, TL ;
Hanson, PI ;
Heuser, JE .
JOURNAL OF CELL BIOLOGY, 1997, 138 (04) :759-769
[7]   The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH [J].
Czajkowsky, DM ;
Iwamoto, H ;
Cover, TL ;
Shao, ZF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2001-2006
[8]   LOW PH ACTIVATES THE VACUOLATING TOXIN OF HELICOBACTER-PYLORI, WHICH BECOMES ACID AND PEPSIN RESISTANT [J].
DEBERNARD, M ;
PAPINI, E ;
DEFILIPPIS, V ;
GOTTARDI, E ;
TELFORD, J ;
MANETTI, R ;
FONTANA, A ;
RAPPUOLI, R ;
MONTECUCCO, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :23937-23940
[9]  
DElios MM, 1997, J IMMUNOL, V158, P962
[10]  
DI TA, 1995, INFECT IMMUN, V63, P1102